Silexion Therapeutics ( ($SLXN) ) has shared an announcement. On January 6, 2026, Silexion Therapeutics released a CEO letter to shareholders ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company’s investigational RNA interference (RNAi) ...
Abstract: The management level of Smart Parking Systems (SPS) relies heavily on accurate parking occupancy information, making low-cost, high-precision wireless parking sensors (WPS), powered by ...
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...
Detroit Lions quarterback Jared Goff muscled his way into the end zone as time expired after a lateral from Amon-Ra St. Brown. Detroit thought it won Sunday's game against the Pittsburgh Steelers at ...
The New England Patriots' official playoff spot being locked in appeared to be on hold once again on Sunday night. Needing a win, the Patriots were trailing the Lamar Jackson-less Baltimore Ravens ...
Abstract: Cross-Technology Interference (CTI) poses challenges for the performance and robustness of wireless networks. There are opportunities for better cooperation if the spectral occupation and ...
The field of skin aging research has undergone a remarkable transformation, evolving from descriptive studies to mechanistic investigations that integrate genetics, molecular biology, and personalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback